NCT03869996 Total Knee Arthroplasty: Fast Track Protocol is the Future?
| NCT ID | NCT03869996 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istituto Ortopedico Rizzoli |
| Condition | Osteoarthritis, Knee |
| Study Type | INTERVENTIONAL |
| Enrollment | 64 participants |
| Start Date | 2019-02-25 |
| Primary Completion | 2026-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 64 participants in total. It began in 2019-02-25 with a primary completion date of 2026-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Fast-track total knee arthroplasty (TKA) is a well-established concept including optimized logistics and evidence-based treatment, focusing on minimizing surgical stress and improved post-operative recovery. The aim of this protocol is to compare the standard care and fast track total knee arthroplasties in terms of functional and subjective outcomes, hospital staying, number of transfusions and analgesic consumption.
Eligibility Criteria
Inclusion Criteria: * patients affected by knee osteoarthritis, eligible for primary total knee arthroplasty * BMI \< 32 * Time up ang go test \</= 12 seconds * American Society of Anesthesiologists physical status classification system (ASA) \</= 2 * preoperative hemoglobin (HB) \>13 g/dl * patients eligible for spinal anesthesia * presence of a care-giver Exclusion Criteria: * psychiatric diseases * preoperative use of crutches * ASA \> 3 * preoperative HB \< 13 g/dl
Contact & Investigator
Cesare Stagni, MD
PRINCIPAL INVESTIGATOR
Istituto Ortopedico Rizzoli
Frequently Asked Questions
Who can join the NCT03869996 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 78 Years, studying Osteoarthritis, Knee. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03869996 currently recruiting?
Yes, NCT03869996 is actively recruiting participants. Contact the research team at martina.rocchi@ior.it for enrollment information.
Where is the NCT03869996 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT03869996 clinical trial?
NCT03869996 is sponsored by Istituto Ortopedico Rizzoli. The principal investigator is Cesare Stagni, MD at Istituto Ortopedico Rizzoli. The trial plans to enroll 64 participants.